Kythera Biopharmaceuticals

Focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market in the United States and internationally

Calabasas United States (HQ)

http://kytherabiopharma.com

https://twitter.com/kytherabiopharm http://www.facebook.com/pages/Kythera-Biopharmaceuticals-Inc/159881570711292

Edit

Launch date

Aug 2005

Employees

51-200 people

Ownership

subsidiary, public, venture capital

Firm valuation

Date	Investors	Amount	Round
Sep 2005	Versant Ventures	$1m	SEED
Jul 2006	Prospect Venture Partners ARCH Venture Partners Altitude Life Science Ventures Versant Ventures Wilson Sonsini Goodrich & Rosati UCLA VC Fund	$10m	SERIES B
May 2008	Prospect Venture Partners ARCH Venture Partners Altitude Life Science Ventures Versant Ventures WS Investments BB&T Jafco Life Science Apothecary Capital	$30m	SERIES C
Sep 2011	Latham & Watkins Invus Prospect Venture Partners ARCH Venture Partners Altitude Life Science Ventures Versant Ventures Foley Ventures BB&T	$37.4m	SERIES D
Oct 2012	N/A	$70.4m	IPO
Jun 2015	Allergan	$2.1b Valuation: $2.1b	ACQUISITION
Total Funding		€71.3m

Are you an employee or an investor of this company?

Add your profile

Kythera Biopharmaceuticals

Company information

Kythera Biopharmaceuticals funding

Kythera Biopharmaceuticals investors

Recent News about Kythera Biopharmaceuticals